Risk Reduction Solutions for
Pharmaceutical, Life Sciences & Healthcare
Bioquell and COVID-19
Learn more about Bioquell and Ecolabs response, our solutions, the latest news, and key information about the COVID-19 pandemic.
Leading Biodecontamination experts Bioquell warmly welcomes the latest publication by the HSE highlighting the timescale for hydrogen peroxide-based biocides to be compliant.
The HSE Biocides e-Bulletin 22 September 2016 is entitled ‘Active Substance Approval Reminder’ and summarises all of the key dates for the evaluation of hydrogen peroxide in Product Types 1, 2, 3, 4, 5 and 6 under the EU Biocides Regulation 528/2012 (EU BPR).
They confirm that hydrogen peroxide will be approved on 1 February 2017 for use in biocidal products placed on the EU market. All affected companies are reminded that they must apply for UK product authorisation by 1 February 2017 in order to keep their biocidal products on the UK market after the active substance approval date, 1 February 2017.
John Chewins, Bioquell’s Director, Scientific & Regulatory Affairs said, “Biocidal products containing this active substance will therefore need to obtain EU BPR authorisation if they are to remain on the market. Bioquell has already made all the appropriate steps to ensure our market leading product will continue to be on the market going forwards, helping our customers eliminate pathogens and control bioburden.”
The HSE Biocides e-Bulletin 22 September 2016 – Active Substance Approval Reminder can be found here https://content.govdelivery.com/accounts/UKHSE/bulletins/165c362